The DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Microglial priming in Alzheimer’s disease
Open accessAbstract
Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disease of central nervous system (CNS). Nowadays, increasing evidence suggests that immune system plays a significant role in the mechanisms of AD's onset and progression. Microglia, the main participator in the immune system of CNS, is always regarded as a protector of our brain in a healthy state and also has a beneficial role in maintaining the homeostasis of CNS microenvironment. However, chronic and sustained stimulation can push microglia into the state termed priming. Primed microglia can induce the production of amyloid β (Aβ), tau pathology, neuroinflammation and reduce the release of neurotrophic factors, resulting in loss of normal neurons in quantity and function that has immense relationship with AD. The therapeutic strategies mainly aimed at modulating the microenvironment and microglial activity in CNS to delay progression and alleviate pathogenesis of AD. Overall, in this review, we highlight the mechanism of microglial priming, and discuss the profound relationship between microglial priming and AD. Besides, we also pay attention to the therapeutic strategies targeting at microglial priming.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The effort to find an innovative non-amyloid-based compound acting on neuroinflammation could be another treatment option since the growing body of evidence supports the involvement of the neuroimmune system, mast cells (MCs), and microglia in AD onset and progression [125,126].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [125]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Primed microglia can stimulate the release of Aβ and tau protein with the following formation of neuritic plaques and neurofibrillary tangles, as well as reducing the production of neurotrophic factors [125].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 1×
“In a nutshell, a wealth of evidence indicates that microglia have an irreplaceable role in brain development and are important in synaptic pruning and clearing cell debris (12-14).”
BackgroundComplement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 2×
“In the past several years, emerging lines of evidence have suggested that intricate neuroinflammation as a significant contributor to the priming of microglia, and all the above situations are closely related to neuroinflammation (17,21-23).”
BackgroundScheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Research works printed but not linked: 1
- Guerreiro R, Hardy J. TREM2 and neurodegenerative disease. N Engl J Med 2013;369:1569-70.
Cited by
Sorted by citations
Glial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274
Passamonti, L., Tsvetanov, K. A., Jones, P. S., Bevan-Jones, W. R., Arnold, R., Borchert, R. J., Mak, E., Su, L., O'Brien, J. T., & Rowe, J. B. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2574-18.2019 · Cited by 220
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158
He, P., Yan, S., Zheng, J., Gao, Y., Zhang, S., Liu, Z., Liu, X., & Xiao, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03731 · Cited by 122
Salas-Venegas, V., Flores-Torres, R. P., Rodríguez-Cortés, Y. M., Rodríguez-Retana, D., Carreto, R. J. R., Concepción-Carrillo, L. E., Pérez-Flores, L. J., Alarcón‐Aguilar, A., López‐Díazguerrero, N. E., Gómez‐González, B., et al. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.798995 · Cited by 126
Dubois, B., López‐Arrieta, J., Lipschitz, S., Doskas, T. K., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01169-x · Cited by 123
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94
“The effort to find an innovative non-amyloid-based compound acting on neuroinflam-mation could be another treatment option since the growing body of evidence supports the involvement of the neuroimmune system, mast cells (MCs), and microglia in AD onset and progression [125,126].”
BackgroundMahato, S., & Ghosh, K. G. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109835 · Cited by 74
Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
Kantarcı, A., Tognoni, C. M., Yaghmoor, W., Marghalani, A. A., Stephens, D. N., Ahn, J.-Y., Carreras, I., & Dedeoglu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75517-4 · Cited by 72
Barnett, A., David, E., Rohlman, A., Nikolova, V. D., Moy, S. S., Vetreno, R. P., & Coleman, L. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884170 · Cited by 60
Estfanous, S. Z. K., Daily, K. P., Eltobgy, M. M., Deems, N. P., Anne, M. N. K., Krause, K., Badr, A., Hamilton, K., Carafice, C., Hegazi, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705581 · Cited by 64
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 68
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 64
Lee, H., Jeon, S. G., Kim, J., Kang, R. J., Kim, S., Han, K., Park, H., Kim, K., Sung, Y. M., Nam, H. Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13332 · Cited by 62
Mira, R. G., Tapia‐Rojas, C., Maria Jose Perez, J., Jara, C., Vergara, E. H., Quintanilla, R. A., & Cerpa, W. F. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107628 · Cited by 57
SARS-CoV-2 involvement in central nervous system tissue damage
Sabra, M., Kobeissy, F. H., Bizri, M., Haidar, M. A., Shakkour, Z., Reslan, M. A., Al-Haj, N., Chamoun, P., Habashy, K. J., Kaafarani, H., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327323 · Cited by 58
Son, Y., Jeong, Y. J., Shin, N., Oh, S. J., Nam, K. R., Choi, H., Choi, J. Y., & Lee, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155553 · Cited by 53
Hao, X., Li, Z., Li, W., Katz, J., Michalek, S. M., Barnum, S. R., Pozzo‐Miller, L. D., Saito, T., Saido, T. C., Wang, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.816640 · Cited by 56
Towards an adiposity-related disease framework for the diagnosis and management of obesities
Perdomo, C. M., Avilés-Olmos, I., Dicker, D., & Frühbeck, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09797-2 · Cited by 51
Hampel, H. J., Lista, S., Néri, C., & Vergallo, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101662 · Cited by 47
Sanchez‐Bezanilla, S., Hood, R. J., Collins‐Praino, L. E., Turner, R. J., Walker, F. R., Nilsson, M., & Ong, L. K. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211005877 · Cited by 47
Jiang, L., Mu, H., Xu, F., Xie, D., Su, W., Xu, J., Sun, Z., Liu, S., Luo, J., Shi, Y., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20902542 · Cited by 46
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Shin, H. J., Kim, I. S., Choi, S. G., Lee, K., Park, H., Shin, J., Kim, D., Beom, J., Yi, Y. Y., Gupta, D. P., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00715-x · Cited by 45
Kim, S., Sharma, C., Jung, U. J., & Kim, S. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051383 · Cited by 40
Chen, N., Chen, X., Xie, J., Wu, C., & Qian, J. X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10438 · Cited by 39
Deleterious Alteration of Glia in the Brain of Alzheimer’s Disease
Kim, E., Otgontenger, U., Jamsranjav, A., & Kim, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186676 · Cited by 42
Pastorello, Y., Carare, R. O., Bănescu, C. V., Potempa, L. A., Napoli, M. D., & SLEVIN, M. A. (2023) · Brain Pathology · doi:10.1111/bpa.13164 · Cited by 35
Valentin‐Escalera, J., Leclerc, M., & Calon, F. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230118 · Cited by 37
Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases
Lin, M., Yu, H., Xie, Q., Xu, Z., & Shang, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1100133 · Cited by 37
Brain amyloid in virally suppressed HIV-associated neurocognitive disorder
Howdle, G. C., Quidé, Y., Kassem, M. S., JOHNSON, K., Rae, C. D., Brew, B. J., & Cysique, L. A. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000739 · Cited by 35
Fernández‐Mendívil, C., Arreola, M. A., Hohsfield, L. A., Green, K. N., & López, M. G. (2020) · Antioxidants · doi:10.3390/antiox9070644 · Cited by 33
Nagata, C., Hata, M., Miyazaki, Y., Masuda, H., Wada, T., Kimura, T., Fujii, M., Sakurai, Y., Matsubara, Y., Yoshida, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48418-5 · Cited by 32
Taj, T., Kaushik, M., Islam, A., Das, J., Kumar, B., Hussain, M. S., Ramzan, M., Ashique, S., Tariq, M., Sridhar, S. B., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118861 · Cited by 35
New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
Li, N., Deng, M., Hu, G., Li, N., Yuan, H., & Zhou, Y. (2022) · Biomolecules · doi:10.3390/biom12111722 · Cited by 30
Thomas, S. D., Abdalla, S., Eissa, N., Akour, A. A., Jha, N. K., Ojha, S. K., & Sadek, B. S. (2024) · Pharmaceuticals · doi:10.3390/ph17070831 · Cited by 33
The Impact of Ageing on the CNS Immune Response in Alzheimer’s Disease
Chee, S. E. J., & Solito, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738511 · Cited by 29
Liu, G., Yu, Q., Zhu, H., Tan, B., Yu, H., Li, X., Lu, Y., & Li, H. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04948-9 · Cited by 30
Genetics of Alzheimer’s disease
König, T., & Stögmann, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00819-9 · Cited by 31
Karagyaur, M. N., Станиславович, Д. С., Basalova, N. A., Aleksandrushkina, N. A., Sagaradze, G. D., Danilova, N. V., Malkov, P. G., Popov, V. S., Никитична, С. М., Efimenko, A. Y., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122031 · Cited by 27
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 29
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
Kopp, K. O., Greer, M. E., Glotfelty, E. J., Hsueh, S., Tweedie, D., Kim, D. S., Reale, M., Vargesson, N., & Greig, N. H. (2023) · Biomolecules · doi:10.3390/biom13050747 · Cited by 26
Mackey-Alfonso, S. E., Butler, M. J., Taylor, A., Williams-Medina, A. R., Muscat, S. M., Fu, H., & Barrientos, R. M. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.021 · Cited by 25
Caruso, G., Pietro, L. D., & Caraci, F. (2023) · Biomolecules · doi:10.3390/biom13030505 · Cited by 24
NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer’s Disease
Bellozi, P. M. Q., Gomes, G. F., de Oliveira, L. R., Olmo, I. G., Vieira, É. L. M., Ribeiro, F. M., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01345 · Cited by 22
Phirom, K., Nantakool, S., Chuatrakoon, B., & Rerkasem, K. (2025) · Public Health · doi:10.1016/j.puhe.2025.01.040 · Cited by 18
Systemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
Bathini, P., Dupanloup, I., Zenaro, E., Terrabuio, E., Fischer, A., Ballabani, E., Doucey, M., & Alberi, L. A. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100568 · Cited by 22
Salas-Venegas, V., Santín-Márquez, R., Carreto, R. J. R., Rodríguez-Cortés, Y. M., Cano-Martínez, A., Luna‐López, A., Chavarría, A., Königsberg, M., & López‐Díazguerrero, N. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1162747 · Cited by 21
Daily, K. P., Badr, A., Eltobgy, M. M., Estfanous, S. Z. K., Whitham, O. D., Tan, M. H., Carafice, C., Krause, K., McNamara, A. J., Hamilton, K., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01390-2 · Cited by 24
Intermittent hypoxia treatments cause cellular priming in human microglia
Felice, M. D., Germelli, L., Piccarducci, R., Pozzo, E. D., Giacomelli, C., Baccaglini‐Frank, A., & Martini, C. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17682 · Cited by 16
Rajendran, K., Chellappan, D. R., Sankaranarayanan, S., Ramakrishnan, V., & Krishnan, U. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104890 · Cited by 17
Majumdar, S., Samaiya, P. K., Gupta, S. K., Krishnamurthy, S., & Prajapati, S. K. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103042 · Cited by 18
Immunological Interfaces: The COVID-19 Pandemic and Depression
Perlmutter, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.657004 · Cited by 18
Dietary fat: a potent microglial influencer
Ceasrine, A. M., & Bilbo, S. D. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.12.005 · Cited by 17
Saucier, J., Comeau, D., Robichaud, G. A., & Chamard-Witkowski, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1221266 · Cited by 16
Ghosh, S., Debnath, I., Bhunia, S., Nandi, S., Ashique, S., Nayak, A., Mallick, S., & Basak, S. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.09.005 · Cited by 16
Possible Implications of Obesity-Primed Microglia that Could Contribute to Stroke-Associated Damage
Carreto, R. J. R., Rodríguez-Cortés, Y. M., Guerrero, H. T., & Chavarría, A. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01329-5 · Cited by 15
Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
Alshamrani, M. (2023) · Antibodies · doi:10.3390/antib12020041 · Cited by 17
Decoding molecular mechanisms: brain aging and Alzheimer’s disease
Hayat, M., Syed, R. A., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R. A., Albassam, L. A. M., Kaleem, I., Wang, X., Wang, R., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01403 · Cited by 14
Yassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
Zhou, T., Zhuang, J., Wang, Z., Zhou, Y., Li, W., Wang, Z., & Zhu, Z. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001202 · Cited by 14
Tok, S., Maurin, H., Delay, C., Crauwels, D., Manyakov, N. V., der Elst, W. V., Moechars, D., & Drinkenburg, W. H. I. M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01393-w · Cited by 14
Goyal, L., & Singh, S. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273318552240708055413 · Cited by 13
Zou, Y., Wang, C., Li, H., Zhong, M., Lin, J., Hu, Y., Chen, Z., & Gan, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1500105 · Cited by 13
Traumatic Brain Injury and Opioids: Twin Plagues of the Twenty-First Century
Jammoul, M., Jammoul, D., Wang, K., Kobeissy, F. H., & DePalma, R. G. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.05.013 · Cited by 12
Станиславович, Д. С., Литвинова, С. А., Efimenko, A. Y., Aleksandrushkina, N. A., Basalova, N. A., Abakumov, M. A., Danilova, N. V., Malkov, P. G., Balabanyan, V. Y., Безуглова, Т. В., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061346 · Cited by 12
The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases
Papageorgakopoulou, M. A., Bania, A., Lagogianni, I.-A., Birmpas, K., & Assimakopoulou, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03947-6 · Cited by 13
Potential anti-neuroinflammatory compounds from Australian plants – A review
Singh, A., Raju, R., & Münch, G. W. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104897 · Cited by 11
Neuroprotective Effects of Apple‐Derived Drinks in a Mice Model of Inflammation
Alvariño, R., Alonso, E., Alfonso, A., & Botana, L. M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901017 · Cited by 11
Che, Y., He, J., Li, X., Wu, D., Zhang, Y., & Gui-cai, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2038448 · Cited by 10
Ceasrine, A. M., Batorsky, R., Shook, L. L., Kışlal, S., Bordt, E. A., Devlin, B. A., Perlis, R. H., Slonim, D. K., Bilbo, S. D., & Edlow, A. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471177 · Cited by 9
Lee, J. H., Chang, W. S., Min, S. S., Song, D., & Yoo, H. (2025) · Cells · doi:10.3390/cells14171342 · Cited by 8
Liu, J., Zhou, J., You, C., Xia, H., Gao, Y., Liu, Y., & Gong, X. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1435082 · Cited by 10
Latham, A. S., Geer, C. E., Ackart, D. F., Anderson, I. K., Vittoria, K. M., Podell, B. K., Basaraba, R. J., & Moreno, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1157652 · Cited by 9
Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9
Moreira, P., Macedo, J., Matos, P., Bicker, J., Fortuna, A. C., Figueirinha, A., Salgueiro, L., Batista, M. T., da Silva, A. P., Silva, S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117652 · Cited by 7
Ko, Y., Ryu, Y., Han, S.-J., Park, H. J., Choi, M., Kim, B. C., Jeong, H., Jang, S., Jo, J., Lee, S., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01040-1 · Cited by 7
Blood Analytes as Biomarkers of Mechanisms Involved in Alzheimer’s Disease Progression
Baldini, A., Greco, A., Lomi, M., Giannelli, R., Canale, P., Diana, A., Dolciotti, C., Carratore, R. D., & Bongioanni, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113289 · Cited by 6
Salminen, A. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106115 · Cited by 5
Veneziani, I., Grimaldi, A., Marra, A., Morini, E., Culicetto, L., Marino, S., Quartarone, A., & Maresca, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082307 · Cited by 5
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection
Ohene, Y., Morrey, W. J., Powell, E., Smethers, K. F., Luka, N., South, K., Berks, M., Lawrence, C. B., Parker, G. J. M., Parkes, L. M., et al. (2025) · npj Imaging · doi:10.1038/s44303-025-00071-5 · Cited by 7
Ma, X., Zhiming, H., Mingwen, S., Hong, W., Tao, Y., Jun, X., & Gong, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-94861-x · Cited by 5
Perinatal asphyxia and Alzheimer's disease: is there a correlation?
Arruda, B. P., Martins, P. P., Kihara, A. H., & Takada, S. H. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1567719 · Cited by 5
Low, Y. L., Pan, Y., Short, J. L., & Nicolazzo, J. A. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113575 · Cited by 5
The Impact of Edentulism and Periodontitis on Cognition
Berard, L., & Zhou, M. (2023) · Journal of the California Dental Association · doi:10.1080/19424396.2023.2289696 · Cited by 4
Microglial Hemoxygenase-1 Deletion Reduces Inflammation in the Retina of Old Mice with Tauopathy
Fernández‐Albarral, J. A., Salobrar‐García, E., Matamoros, J. A., Fernández‐Mendívil, C., del Sastre, E., Chen, L., de Hoz, R., López‐Cuenca, I., Sánchez-Puebla, L., Ramirez, J. M., et al. (2022) · Antioxidants · doi:10.3390/antiox11112151 · Cited by 4
Cho, H., Choi, B. Y., Shin, Y., Suh, S. W., & Park, S. B. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00508 · Cited by 4
Caesarine, A., Batorsky, R., Shook, L. L., Kışlal, S., Bordt, E. A., Devlin, B. A., Perlis, R. H., Slonim, D. K., Bilbo, S. D., & Edlow, A. G. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3985607 · Cited by 4
Daily, K. P., Badr, A., Eltobgy, M. M., Estfanous, S. Z. K., Whitham, O. D., Tan, M. H., Carafice, C., Krause, K., McNamara, A. J., Hamilton, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555526 · Cited by 4
Herpesvirus initiation of dementias and autoimmune diseases
Roe, K. (2025) · Journal of NeuroVirology · doi:10.1007/s13365-025-01265-8 · Cited by 3
Lima, V. D. S., Emerick, G. L., Sinhorin, V. D. G., Lima, R. R. D. S., da Silva, H. S., da Silva, K. F., de Sousa, A. C. A., Silveira, F. R., Saito, A. L. M., Estevam, E. L., et al. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138462 · Cited by 3
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
LPS-Induced Neuroinflammation in Neurodegenerative Diseases: A Double-Edged Sword?
Mohammadi, A., Aghajan, A., Alipour, M., Ghorbani, A., Limoodehi, S. M., & Hedayati, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06004-6 · Cited by 2
Yuan, N. Y., Richards, W. D., Parham, K. T., Clark, S. G., & Lebakken, C. S. (2026) · Cells · doi:10.3390/cells15141266 · Cited by 2
Abdel‐Aal, R. A., Farghaly, H. S. M., & Zakaria, A. (2018) · Journal of Current Medical Research and Practice · doi:10.4103/jcmrp.jcmrp_110_18 · Cited by 2
Neuroinflammation in Huntington’s Disease
Lee, J. D., Lo, M. W., Fung, J. N., & Woodruff, T. M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_9 · Cited by 2
Metabolic and epigenetic regulation of microglia memory in neurological disorders
Wang, X., Jia, Y., Yan, X. Z., & Wang, Y. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag085 · Cited by 1
Chromatin Dynamics and Genetic Variation Combine to Regulate Innate Immune Memory.
Kim, J. S., & Ciernia, A. V. (2020) · PubMed
Metadata
- Authors
- Li, J.-W., Zong, Y., Cao, X.-P., Tan, L., & Tan, L.
- Affiliations
- Qingdao University (CN)
- Corresponding author
- Tan, Lin
- Tan, Lan
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2018-05
- Volume
- 6
- Issue
- 10
- Pages
- 176-176
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- PMC
- PMC5994530
- OpenAlex
- W2800869030
- Cited by
- 122
- References
- 133
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 26 · 2023: 22 · 2022: 13 · 2021: 18 · 2020: 13 · 2019: 9 · 2018: 2
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Annals of Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Qingdao Key Health Discipline Development Fund
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microglial priming, microglia, neuroinflammation, amyloid-beta, tau pathology, neurotrophic factors, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review